MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.570
-0.140 (-2.97%)
At close: Jul 6, 2026, 4:00 PM EDT
4.734
+0.164 (3.58%)
After-hours: Jul 6, 2026, 7:53 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $290.48 million as of July 6, 2026. Its market cap has increased by 236.21% in one year.
Market Cap
290.48M
Enterprise Value
172.76M
1-Year Change
236.21%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $290.48M, a decrease of -51.61%. That is a compound annual growth rate of -5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 290.48M | 185.35% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 317.49M |
| Foghorn Therapeutics | 311.18M |
| Cartesian Therapeutics | 311.15M |
| Neumora Therapeutics | 309.42M |
| Eledon Pharmaceuticals | 305.34M |
| Bicycle Therapeutics | 303.68M |
| SAB Biotherapeutics | 299.74M |
| Galectin Therapeutics | 297.01M |